Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion

/PRNewswire/ -- Theradaptive, a privately held biopharmaceutical company pioneering a new class of regenerative implants announced that the U.S. Food and Drug...

Related Keywords

Boston ,Massachusetts ,United States ,Massachusetts Institute Of Technology ,Mark Shasti ,John Greenbaum ,Serena Lertora ,Breakthrough Devices Program ,Drug Administration ,Clinical Regulatory Affairs At Theradaptive ,Us Department Of Defense ,Breakthrough Medical Device ,Breakthrough Designation ,Inova Loudoun ,Senior Vice President ,Regulatory Affairs ,Precision Regenerative Implants ,Massachusetts Institute ,Theradaptive ,